New hope for Tough-to-Treat blood cancer: major trial tests promising drug
NCT ID NCT07258511
Summary
This study is testing a new drug called JNJ-79635322 to see if it works better than an existing treatment for multiple myeloma, a type of blood cancer. It is for people whose cancer has come back or stopped responding after trying at least three other types of therapy. The main goals are to see if the new drug shrinks the cancer more effectively and keeps it from getting worse for a longer time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assuta MC
RECRUITINGTel Aviv, 69710, Israel
-
Baruch Padeh MC
RECRUITINGRamat Poriya, 1520800, Israel
-
Bnai Zion Medical Center
RECRUITINGHaifa, 31048, Israel
-
Box Hill Hospital
RECRUITINGBox Hill, 3128, Australia
-
Carmel Medical Center
RECRUITINGHaifa, 34362, Israel
-
Chiba Cancer Center
RECRUITINGChiba, 260 0801, Japan
-
Durham VAMC
RECRUITINGDurham, North Carolina, 27705, United States
-
Emory University
RECRUITINGAtlanta, Georgia, 30322, United States
-
Florida Cancer Specialists & Research Institute
RECRUITINGFort Myers, Florida, 33901, United States
-
Gold Coast University Hospital
RECRUITINGSouthport, 4215, Australia
-
Hospital De Clinicas De Porto Alegre
SUSPENDEDPorto Alegre, 90035 903, Brazil
-
Icahn School of Medicine at Mount Sinai
RECRUITINGNew York, New York, 10029, United States
-
Japanese Red Cross Medical Center
RECRUITINGShibuya City, 150-8935, Japan
-
Kameda Medical Center
RECRUITINGKamogawa, 296-8602, Japan
-
Mater Misericordiae Ltd
RECRUITINGBrisbane, 4101, Australia
-
Memorial Sloan Kettering Cancer Center
RECRUITINGNew York, New York, 10065, United States
-
Mount Sinai Chelsea
RECRUITINGNew York, New York, 10011, United States
-
Norton Cancer Institute
RECRUITINGLouisville, Kentucky, 40207, United States
-
Oregon Health And Science University
RECRUITINGPortland, Oregon, 97239, United States
-
Rambam Medical Center
RECRUITINGHaifa, 3109601, Israel
-
Shaare Zedek MC
RECRUITINGJerusalem, 9103102, Israel
-
Sheba Medical Center
RECRUITINGRamat Gan, 52621, Israel
-
Shonan Kamakura General Hospital
RECRUITINGKamakura-shi, 247-8533, Japan
-
Soroka Medical Center
RECRUITINGBeersheba, 8457108, Israel
-
St Vincents Hospital Melbourne
RECRUITINGFitzroy, 3065, Australia
-
The Alfred Hospital
RECRUITINGMelbourne, 3004, Australia
-
The Jikei University Hospital
RECRUITINGMinato, 105-8471, Japan
-
Thomas Jefferson University Hospital
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
RECRUITINGBunkyō City, 113 8677, Japan
-
USC Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
-
University of Connecticut Health Center
RECRUITINGFarmington, Connecticut, 06030, United States
-
Yale Cancer Center
RECRUITINGNew Haven, Connecticut, 06510, United States
-
Yamanashi Prefectural Central Hospital
RECRUITINGKofu, 400-0027, Japan
Conditions
Explore the condition pages connected to this study.